We found that among the PSMA-11-positive ganglia and lymph node metastases, 62.7% of the lymph node metastases were FDG-positive, while only 13.6% of the ganglia were FDG-positive. This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.